Heather L. Mason, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 39,679 shares at $58.43 ($2.3M) on 2012-03-13, disclosed to the SEC on 2012-03-15.
Scheduled sale ($2.3M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.40 | 1,700 | $99K | 4.3% |
| 2 | $58.41 | 300 | $18K | 0.8% |
| 3 | $58.41 | 400 | $23K | 1.0% |
| 4 | $58.42 | 1,900 | $111K | 4.8% |
| 5 | $58.42 | 4,200 | $245K | 10.6% |
| 6 | $58.42 | 100 |
| $6K |
| 0.3% |
| 7 | $58.43 | 14,721 | $860K | 37.1% |
| 8 | $58.43 | 500 | $29K | 1.3% |
| 9 | $58.43 | 1,000 | $58K | 2.5% |
| 10 | $58.44 | 900 | $53K | 2.3% |
| 11 | $58.44 | 10,258 | $599K | 25.9% |
| 12 | $58.44 | 100 | $6K | 0.3% |
| 13 | $58.45 | 3,500 | $205K | 8.8% |
| 14 | $58.45 | 100 | $6K | 0.3% |
| Total | $58.43 avg | 39,679 | $2.3M | 100% |
| Filing → |
| ASRT | SELL | 2023-05-22 | $1.3M | — | Filing → |
| ABT | SELL | 2017-03-02 | $162K | — | Filing → |
| ABT | SELL | 2017-02-02 | $1.5M | — | Filing → |